A Randomized, Double-blind, Parallel-group Study to Investigate the Efficacy, Safety and Tolerability of Cariprazine in Patients with Predominant Negative Symptoms of Schizophrenia
Latest Information Update: 01 Dec 2023
At a glance
- Drugs Cariprazine (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Registrational; Therapeutic Use
- Sponsors Gedeon Richter
- 01 Nov 2023 Results of post hoc analysis assessing Single trajectory treatment response for predominant negative symptoms published in the Schizophrenia Research
- 18 Oct 2023 According to a Gedeon Richter media release, post-hoc analysis results from this trial were presented as a poster during the 36th Annual Meeting of the European College of Neuropsychopharmacology (ECNP).
- 05 Oct 2021 Results of post-hoc analysis presented at the 34th Annual Congress of the European College of Neuropsychopharmacology.